Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
4.480
-0.390 (-8.01%)
At close: May 9, 2025, 4:00 PM
4.345
-0.135 (-3.01%)
After-hours: May 9, 2025, 7:52 PM EDT

Aligos Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Revenue
3.273.9515.5313.914.36-
Upgrade
Revenue Growth (YoY)
-76.29%-74.60%11.66%219.04%--
Upgrade
Cost of Revenue
70.2770.2773.0485.08104.1579.89
Upgrade
Gross Profit
-67-66.32-57.51-71.17-99.79-79.89
Upgrade
Selling, General & Admin
21.2222.8329.8926.4128.5317.94
Upgrade
Research & Development
-1.86-----
Upgrade
Operating Expenses
19.3522.8329.8926.4128.5317.94
Upgrade
Operating Income
-86.35-89.15-87.4-97.58-128.32-97.83
Upgrade
Interest Expense
------0.24
Upgrade
Interest & Investment Income
0.971.674.31.520.241.26
Upgrade
Currency Exchange Gain (Loss)
-0-0-0.05-0.04-0.010.12
Upgrade
Other Non Operating Income (Expenses)
32.47-43.39-3.010.16-0.1-11.68
Upgrade
EBT Excluding Unusual Items
-52.91-130.88-86.16-95.94-128.19-108.38
Upgrade
Asset Writedown
---0.72---
Upgrade
Pretax Income
-52.91-130.88-86.88-95.94-128.19-108.38
Upgrade
Income Tax Expense
0.350.330.80.110.140.16
Upgrade
Net Income
-53.26-131.21-87.68-96.05-128.33-108.54
Upgrade
Net Income to Common
-53.26-131.21-87.68-96.05-128.33-108.54
Upgrade
Shares Outstanding (Basic)
-63220
Upgrade
Shares Outstanding (Diluted)
-63220
Upgrade
Shares Change (YoY)
-144.38%50.10%7.12%299.03%397.63%
Upgrade
EPS (Basic)
--20.94-34.20-56.24-80.50-271.68
Upgrade
EPS (Diluted)
--20.94-34.20-56.25-80.50-271.68
Upgrade
Free Cash Flow
-79.01-80.87-79.02-80.33-116.55-76.33
Upgrade
Free Cash Flow Per Share
--12.91-30.82-47.04-73.11-191.04
Upgrade
Operating Margin
-2640.70%-2259.92%-562.84%-701.66%-2943.82%-
Upgrade
Profit Margin
-1628.75%-3326.01%-564.62%-690.63%-2944.07%-
Upgrade
Free Cash Flow Margin
-2416.21%-2050.01%-508.83%-577.64%-2673.87%-
Upgrade
EBITDA
-85.41-88.13-85.84-95.27-125.3-95.1
Upgrade
D&A For EBITDA
0.941.031.562.313.022.74
Upgrade
EBIT
-86.35-89.15-87.4-97.58-128.32-97.83
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q